Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Affinium began an open-label, U.S. and Canadian Phase II trial to evaluate 200 mg oral AFN-1252 twice daily for 5-14 days in about 100 patients with staphylococcal skin infections. ...